Seeking Alpha

Regeneron Pharma (REGN): Q4 EPS of $1.47 beats by $0.23. Revenue of $415M beats by $22.36M. (PR)

Regeneron Pharma (REGN): Q4 EPS of $1.47 beats by $0.23. Revenue of $415M beats by $22.36M. (PR)
From other sites
Comments (1)
  • 31nottinham
    , contributor
    Comments (8) | Send Message
     
    This qt was a test, as patients moved from treatment every month to every other month, how would revenue growth be impacted, looks like REGN came through with flying colors
    14 Feb 2013, 08:00 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs